• LevelJump Healthcare Corp. (JUMP) has qualified to trade on the OTCQB® Venture Market
  • Shares of Leveljump will commence trading at the open on May 12th under the symbol JMPHF
  • The OTCQB Venture Market is for entrepreneurial and development stage U.S. and international companies
  • Trading on the OTCQB Market will provide LevelJump access to the U.S. capital markets and investors
  • LevelJump Healthcare Corp. (JUMP) owns and operates Canadian Teleradiology services
  • LevelJump Healthcare Corp. (JUMP) is down 4.88 per cent, trading at C$0.195 per share at 4 pm ET

LevelJump Healthcare Corp. (JUMP) has qualified to trade on the OTCQB® Venture Market.

Shares of Leveljump will commence trading at the open on May 12th under the symbol JMPHF.

The OTCQB Venture Market is for entrepreneurial and development stage U.S. and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. Trading on the OTCQB Market is intended to offer companies efficient, cost-effective access to the U.S. capital markets.

For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the U.S.

“We are extremely proud to announce the commencement of trading on the OTCQB Venture Market,” said Mitch Geisler, CEO and Chairman of Leveljump.

“We are excited to share our vision for Leveljump with a wider pool of retail and institutional shareholders throughout the United States.”

“We are pleased to welcome Leveljump Healthcare Corp. to the OTCQB Venture Market,” said Jason Paltrowitz, EVP of Corporate Services at OTC Markets Group.

“Trading on the TSX Venture Exchange in Canada and on the OTCQB Market in the U.S. will enable Leveljump to more efficiently build global investor awareness. We look forward to supporting the company and its shareholders.”

LevelJump Healthcare Corp. (JUMP) owns and operates Canadian Teleradiology services. JUMP plans to expand through the acquisition of independent healthcare facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.

LevelJump Healthcare Corp. (JUMP) is down 4.88 per cent, trading at C$0.195 per share at 4 pm ET.

More From The Market Online

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.